Stargardt Disease Treatment. What is Stargardt Disease? Stargardt disease is the most common form of inherited juvenile macular degeneration. It is a bilateral symmetric maculopathy, represents the 7% of all retinal hereditary dystrophies with prevalence of 1/10.000. Currently, no medical treatment has been shown to increase vision in Stargardt diseases patients. First successful treatment in Stargardt disease patients In February 2018 a first of kind study was published in EC Ophthalmology, demonstrating significant vision improvement in 10 eyes of 5 patients suffering from stargardt, who were treated with RevitalVision, a unique clinically proven perceptual learning software program that enhance visual processing in the primary visual cortex. The uniqueness of this study is its approach to try and improve the processing of the damaged image, rather than treat the sick eye. For more information on this effective stargardt disease treatment click here.
What are the symptoms of Stargardt disease?